Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels.
about
Alzheimer's disease; taking the edge off with cannabinoids?Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's DiseaseEndocannabinoid signalling in reward and addiction.Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?Endocannabinoids in synaptic plasticity and neuroprotection.The endocannabinoid system as a target for the treatment of neurodegenerative disease.Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons.Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's diseaseEndocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults.Regulation of neurite outgrowth by G(i/o) signaling pathways.Molecular reorganization of endocannabinoid signalling in Alzheimer's diseaseAdelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats.An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease.Role of the endogenous cannabinoid system in nicotine addiction: novel insights.The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intakeHomeostatic regulation of brain functions by endocannabinoid signalingEndocannabinoid signalling and the deteriorating brainIn vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expressionMonoacylglycerol lipase is a therapeutic target for Alzheimer's diseaseAnti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptorCannabinoid receptor 1 blockade protects human retinal pigment epithelial cells from oxidative injury.The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of actionEndocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort studyInflammation and aging: can endocannabinoids help?Targeting the endocannabinoid system: to enhance or reduce?Selective CB2 up-regulation in women affected by endometrial inflammation.Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon.The multiplicity of action of cannabinoids: implications for treating neurodegeneration.The therapeutic potential of the endocannabinoid system for Alzheimer's disease.A brain on cannabinoids: the role of dopamine release in reward seeking.The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects.Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.Cannabinoids in late-onset Alzheimer's disease.New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.
P2860
Q24681412-9ABF2C3D-EEE1-47A4-A25A-AF5BCC3953D9Q26783325-7C066E80-A6DD-464B-9277-34EB0AD72D4FQ30373359-41236E3A-7355-4E99-84F9-72AF1EDB2D57Q30391852-7C693C90-93AE-42C9-AFD0-9138527C2939Q30493991-519B4536-17F9-47FC-B25B-542859D5D2DAQ30506148-6998733B-D1F1-48CA-A604-E3B5AC43D4DCQ33630562-802F8A9F-248A-4793-AE88-BBBC596F8BEDQ34084682-08310D4C-69A5-477C-91BE-8694769CE8EBQ34098196-C648195A-E8AB-470F-AF42-4F13F110B90CQ34352311-D4FF42F0-4294-4156-805E-6240900614D6Q34627188-CA250DBE-3DCB-4580-B4E9-28FCBC6F92E5Q34642593-B7B807F8-E8FA-4859-8A18-EF55B940A31FQ34746354-4ABC73AF-F41B-4959-BBDC-CB00E0F72884Q34754667-B382EEAC-15EB-48C1-B8C5-9A80B53A195AQ34772868-E458525B-F142-4738-89F6-0834B4A98849Q35159081-024B8A51-4A91-4605-A92D-D23AD4839DE8Q35216481-B3194407-51AC-4842-AEB1-FBAC6921B73EQ35593066-3A8DE40D-0C72-46A2-8766-A4AB98BB8464Q35746303-95C4411F-ABCF-4D88-BC2D-717AE60C7B22Q35754490-4594D0FA-542D-4056-8641-906EABB4B829Q35995720-09E3A589-179B-430B-9996-BB1FC4EE2555Q36358055-2DF99843-550A-4C5E-B01C-165DCD440D25Q36442881-A533AC62-5766-465C-97E4-2256E6D2CB5EQ36485064-79A9BC7F-2D2D-41C7-A5AF-33F73452011DQ36634698-B5DA0C48-9CC6-4396-9EAC-6FA32E68FC85Q36943243-A7FFBAED-AA01-4EA3-956C-3B25A43FE5A7Q37074288-50330AF8-186F-4B00-8377-EB4CE099CC11Q37133525-7D647172-FF3D-40B8-BBB7-EED51DB994F7Q37150745-B4188062-8CCC-4BE5-8F75-BB2D2D272E2AQ37293889-7147719B-B3AA-4832-B6D6-30288EEC23FFQ37371891-5996C171-8F0E-4324-A386-0A810C9C6253Q37793366-46F1A63D-8F25-4928-9834-AF34D26819E8Q37997020-8AC9D507-4672-4418-BFCA-A8A1B01F0444Q38036236-89551161-DF2D-40B9-8401-4E7B2E08476CQ38072364-21136EDD-37CF-416B-892E-189461DBF86CQ38196398-62CA2464-EEC0-40AF-B644-2F643FEE9C72Q38220272-D0C86174-2976-4993-8728-019FEAA0D208Q38383508-430C47BD-F28B-4E02-A3EF-9F8DB507B9A6Q38395251-604C238B-B961-4D3D-934D-D26ADE194A2CQ38566169-019D3DB5-5288-4754-B8A8-166FF4633302
P2860
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Endocannabinoids and beta-amyl ...... ion of endocannabinoid levels.
@en
Endocannabinoids and beta-amyl ...... ion of endocannabinoid levels.
@nl
type
label
Endocannabinoids and beta-amyl ...... ion of endocannabinoid levels.
@en
Endocannabinoids and beta-amyl ...... ion of endocannabinoid levels.
@nl
prefLabel
Endocannabinoids and beta-amyl ...... ion of endocannabinoid levels.
@en
Endocannabinoids and beta-amyl ...... ion of endocannabinoid levels.
@nl
P2093
P50
P921
P1476
Endocannabinoids and beta-amyl ...... ion of endocannabinoid levels.
@en
P2093
D De Filippis
M van der Stelt
S Petrosino
P2888
P304
P356
10.1007/S00018-006-6037-3
P577
2006-06-01T00:00:00Z